2020
Borkowetz A, Lohse-Fischer A, Scholze J, Lotzkat U, Thomas C, Wirth MP, Fuessel S, Erdmann K (2020). Evaluation of MicroRNAs as Non-Invasive Diagnostic Markers in Urinary Cells from Patients with Suspected Prostate Cancer. Diagnostics 10:578
Erdmann K, Salomo K, Klimova A, Heberling U, Lohse-Fischer A, Fuehrer R, Thomas C, Roeder I, Froehner M, Wirth MP, Fuessel S (2020). Urinary MicroRNAs as Potential Markers for Non-Invasive Diagnosis of Bladder Cancer. Int J Mol Sci 21(11):3814
Kreuz M, Otto DJ, Fuessel S, Blumert C, Bertram C, Bartsch S, Loeffler D, Puppel SH, Rade M, Buschmann T, Christ S, Erdmann K, Friedrich M, Froehner M, Muders MH, Schreiber S, Specht M, Toma MI, Benigni F, Freschi M, Gandaglia G, Briganti A, Baretton GB, Loeffler M, Hackermüller J, Reiche K, Wirth M, Horn F (2020). ProstaTrend-A Multivariable Prognostic RNA Expression Score for Aggressive Prostate Cancer. Eur Urol.
Melnikova M, Wauer US, Mendus D, Hilger RA, Oliver TG, Mercer K, Gohlke BO, Erdmann K, Niederacher D, Neubauer H, Buderath P, Wimberger P, Kuhlmann JD, Thomale J (2020). Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells. Mol Oncol 14(4):686-703
Rachner TD, Gobel A, Hoffmann O, Erdmann K, Kasimir-Bauer S, Breining D, Kimmig R, Hofbauer LC, Bittner AK (2020). High serum levels of periostin are associated with a poor survival in breast cancer. Breast Cancer Res Treat 180(2):515-524
Borkowetz A, Froehner M, Rauner M, Conrad S, Erdmann K, Mayr T, Datta K, Hofbauer LC, Baretton GB, Wirth M, Fuessel S, Toma M, Muders MH (2020). Neuropilin-2 is an independent prognostic factor for shorter cancer-specific survival in patients with acinar adenocarcinoma of the prostate. Int J Cancer 146(9):2619-2627.
Schulz A, Gorodetska I, Behrendt R, Fuessel S, Erdmann K, Foerster S, Datta K, Mayr T, Dubrovska A, Muders MH (2020). Linking NRP2 with EMT and Chemoradioresistance in Bladder Cancer. Front Oncol 9:1461.
2019
Rachner TD, Kasimir-Bauer S, Göbel A, Erdmann K, Hoffmann O, Browne A, Wimberger P, Rauner M, Hofbauer LC, Kimmig R, Bittner A-K (2019). Prognostic Value of RANKL/OPG Serum Levels and Disseminated Tumor Cells in Nonmetastatic Breast Cancer. Clin Cancer Res 25(4):1369-1378
2018
Fuessel S, Lohse-Fischer A, Vu Van D, Salomo K, Erdmann K, Wirth MP (2018). Quantification of MicroRNAs in Urine-Derived Specimens. In Schulz WA et al. (eds.): Urothelial Carcinoma: Methods and Protocols, Methods in Molecular Biology, vol. 1655: 201-226, ©Springer Science+Business Media LLC 2017
2017
Erdmann K* & Kaulke K*, Rieger C, Wirth MP, Fuessel S (2017). Induction of alpha‑methylacyl‑CoA racemase by miR‑138 via up‑regulation of β‑catenin in prostate cancer cells. J Cancer Res Clin Oncol 143(11):2201-2210 *Co-first authors
Erdmann K* & Ringel J*, Hampel S, Wirth MP, Fuessel S (2017). Carbon nanomaterials sensitize prostate cancer cells to docetaxel and mitomycin C via induction of apoptosis and inhibition of proliferation. Beilstein J Nanotechnol 8:1307-1317 *Co-first authors
Kaufmann A, Hampel S, Rieger C, Kunhardt D, Schendel D, Füssel S, Schwenzer B, Erdmann K (2017). Systematic evaluation of oligodeoxynucleotide binding and hybridization to modified multi-walled carbon nanotubes. J Nanobiotechnology 15(1):53
2016
Erdmann K* & Kaulke K*, Rieger C, Salomo K, Wirth MP, Fuessel S (2016). MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells. J Cancer Res Clin Oncol 142(11):2249-61 *Co-first authors
2015
Castro Nava A, Cojoc M, Peitzsch C, Cirillo G, Kurth I, Fuessel S, Erdmann K, Kunhardt D, Vittorio O, Hampel S, Dubrovska A (2015). Development of novel radio-chemotherapy approaches targeting prostate tumor progenitor cells using nanohybrids. Int J Cancer 137(10):2492-2503
Cojoc M, Peitzsch C, Kurth I, Trautmann F, Kunz-Schughart LA, Telegeev GD, Stakhovsky EA, Walker JR, Simin K, Lyle S, Fuessel S, Erdmann K, Wirth MP, Krause MP, Baumann M, Dubrovska A (2015). Expression of stem cell marker aldehyde dehydrogenase is regulated by β-catenin/TCF and promotes radioresistance in prostate cancer progenitor cells. Cancer Res 75(7):1482-1494
Toma M, Wehner R, Kloß A, Hübner L, Fodelianaki G, Erdmann K, Füssel S, Zastrow S, Meinhardt M, Seliger B, Brech D, Noessner E, Tonn T, Schäkel K, Bornhäuser M, Bachmann M, Wirth MP, Baretton GB, Schmitz M (2015). Accumulation of tolerogenic 6-sulfo LacNAc+ dendritic cells in renal cell carcinoma is associated with poor prognosis. OncoImmunology 4(6):e1008342
Rieger C, Kunhardt D, Kaufmann A, Schendel D, Huebner D, Erdmann K, Propping S, Wirth MP, Schwenzer B, Fuessel S, Hampel S (2015). Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer. Int J Pharm 479(2):357